| Issue |
Med Buccale Chir Buccale
Volume 22, Number 2, avril 2016
|
|
|---|---|---|
| Page(s) | 83 - 84 | |
| Section | Lettre à la rédaction / Letter to the editor | |
| DOI | https://doi.org/10.1051/mbcb/2016014 | |
| Published online | 18 May 2016 | |
Actualité pharmacologique : un antidote pour un nouvel anticoagulant oral d’action directe, le dabigatran
1
Department of DentistryUniversity Hospital of Dijon,
21079
Dijon,
France
2
EA 481 Integrative Neurosciences and Clinical, University Hospital of
Besançon,
F-25000
Besançon,
France
* Correspondance : Dr Julie Bonnot, julie.bonnot@hotmail.fr
Reçu : 29 Mars 2016
Accepté : 6 Avril 2016
Cet article ne possède pas de résumé.
© Les auteurs, 2016
This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted
use, distribution, and reproduction in any medium, provided the original work is
properly cited
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.
